Tatton Consulting supported Liverpool-based needle-free drug delivery company Medicsen in its successful application to Needle free medicines delivery technologies: Feasibility studies, awarded £99,322 by Innovate UK for the project Needle-free delivery of vaccines using the first wearable ultrasound reusable device.
About the funded R&D project
Needle-based vaccination creates biohazardous sharps waste, requires trained administration and deters a meaningful share of the population. Medicsen’s patented ultrasound permeabilisation technology delivers through the skin without breaking it. This project runs feasibility trials for vaccine delivery using the first wearable reusable device of its kind.
Award details
- Grant awarded: £99,322
- Competition: Needle free medicines delivery technologies: Feasibility studies
- Competition year: 2023/24
- Project: Needle-free delivery of vaccines using the first wearable ultrasound reusable device
- Sector: Vaccines / drug delivery
- UKRI project record: Gateway to Research, project 10114929
- Dataset: Innovate UK funded projects, published 10 August 2026
Tatton Consulting supported the competitive grant application. The award value, competition and project title are taken from UKRI’s published record for this project.
See all Innovate UK awards Tatton Consulting has supported on our grant successes page.
